Erectile Dysfunction Treatment Key Players and their Developments

Who are the Erectile Dysfunction Treatment Market Top Vendors and What are Their Offerings?

Erectile Dysfunction Treatment Market Value Chain Analysis

R&D

• The R&D of the erectile dysfunction treatment focuses on the development of transdermal topical gels, fast-acting oral PDE5 inhibitors, and micro-plaque sonic devices.
• Key players: Futura Medical plc, Vivus LLC, and Strategic Science & Technologies.

Clinical Trials and Regulatory Approvals

• The minimal clinically important difference (MCID), safety, and systemic adverse events are evaluated in the clinical trials and regulatory approvals of the erectile dysfunction treatment.
• Key players: Futura Medical plc, Vivus LLC.

Patient Support and Services

• The digital health platforms, retail programs offering online medical consultations, automated educational resources, and home deliveries are provided in the patient support and services of the erectile dysfunction treatment.
• Key players: Ro, Him & Hers Health, Inc., Haleon plc.

Market Ecosystem Analysis

Recent Developments in the Erectile Dysfunction Treatment Market

• In June 2026, a nationwide telehealth platform designed to help men access personalized erectile dysfunction treatment was launched by Vigo MD. This streamlined digital healthcare solution will offer a convenient, clinician-guided online experience by combining licensed medical evaluations, ongoing provider oversight, discreet medication delivery, and prescription treatment options.
• In February 2026, Vybrique, which is the first oral film formulation of sildenafil for the treatment of erectile dysfunction, was approved by the FDA. The product will be available for men aged 18 years and older, where the tablet dissolves on the tongue without water and is prescribed to be administered between 30 minutes and four hours before sexual activity, with or without food.

Competitive Landscape

Erectile Dysfunction Treatment Market Trends 2026

The global erectile dysfunction treatment market size is calculated at USD 4.98 billion in 2025, driven by growth in the geriatric population and a rise in chronic disease burden. The market continues to grow in 2026 at USD 5.38 billion due to the rising use of AI-enabled healthcare, accelerated drug development, and a rise in the focus on men's healthcare. It is expected to reach USD 10.87 billion by 2035, achieving a CAGR of 8.12% between 2026 and 2035. due to growing interest in regenerative medicines, rising minimally invasive solutions, and technological advancements. North America accounted for 38% of the market in 2025 due to its high ED diagnostic rates, growth in health awareness, and rise in healthcare spending.